Your Formulation Book Is a Depreciating Asset
A chemist pulls a bound notebook off a shelf and lands on the page everyone trusts. The ratios are there. So is the crossed-out trial that saved six weeks. What is not there is ...
Why We Only Buy Founder-Led Businesses
There is a particular silence that happens in a room when a founder decides to sell. Not reluctance, exactly. More like the long pause before someone says something they have been ...
Jeff Bezos Just Validated Our Thesis — Here’s What Project Prometheus Means for Your $20M Manufacturing Company
Somewhere in a specialty chemicals facility right now, a batch is running differently than the last one, and nobody can fully explain why. The viscosity is off. The cure time is ...
What Is an Earnout and Why It Might Work in Your Favor
The first offer felt insulting, which is one way a founder knows the process has become real. The buyer was not arguing about the last three years. The EBITDA was what it was. The ...
Stay Current
Intelligence for industrial operators
New articles on AI, operations, and deal flow -- delivered when it matters. No cadence commitments.
No spam. Unsubscribe at any time.